Navigation Links
Nighttime Home Dialysis a Boon for Kidney Patients
Date:9/18/2007

quent nocturnal dialysis might improve heart health and other results, but no randomized clinical trials had been done comparing the standard dialysis regimen to the at-home treatment.

Culleton and his colleagues recruited 52 dialysis patients and randomly assigned them to receive either conventional dialysis three times a week at a dialysis center or to learn at-home dialysis to be done five to six times a week for at least six hours while they were sleeping.

By the end of the six-month study period, the average left ventricular mass was 15.3 grams more for the conventional dialysis group, compared with the nocturnal dialysis group.

"These patients clearly did have improvements in heart thickness, and other studies have shown that if you reduce the size of the left ventricle, you increase survival," said Dr. Alan Kliger, chairman of medicine at the Hospital of St. Raphael and a clinical professor of medicine at Yale University School of Medicine. Kliger wrote an accompanying editorial in the same issue of the journal.

In addition to the reduction in left ventricular mass, blood pressure dropped as well for the nighttime dialysis group. Systolic blood pressure -- the top number -- went down 7 mm/Hg for the nocturnal dialysis group, compared to a 4 mm/Hg increase for the conventional group. Diastolic blood pressure also dropped 7 mm/Hg for those dialyzing at home, but decreased just 2 mm/Hg for the standard group.

Sixteen out of 26 people in the nocturnal dialysis group were able to stop taking high blood pressure medications, while only three out of 25 in the standard group stopped these medications.

There were also improvements in mineral metabolism, such as calcium and phosphate, and some improvements in quality of life, such as the burden of kidney disease, in the nightly dialysis group.

Both Culleton and Kliger said these improvements were the result of more frequent dialysis for the at-home
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Melatonin Can Help Nighttime Workers Sleep
2. Increased Nighttime BP, a Significant Predictor of Congestive Heart Failure
3. Recognizing heart risk in dialysis patients
4. Easier Dialysis for Kids
5. More Patients Going In For Home Dialysis
6. Dialysis Clinics Owned By Fresenius Flourishes Due To Its Customers
7. SRN Hospital Dialysis Unit To Resume Function
8. Heparin Based Nanoscale Materials Developed For Dialysis Treatment
9. Exercise Combined with Dialysis Yields Better Results
10. Surveillance Program for Haemodialysis Reduces Infection
11. Vitamin E-Coated Dialysis Filters Help Fight Anemia in Hemodialysis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...class of drugs based on a widely used anticancer d...g effects in the laboratory and in mice, according... interesting for the treatment of these tumors. //...rea were extremely active in blocking the same cel...
... Cipro, Cipro. That's been the mantra of the media...usands who weren't -- clamor for the potent antibi...r cheaper and widely available medications can be ...rug: penicillin. Although alternatives exist, Cipr...
...erimental anti-cancer drug has shown effectiveness...ng to a new report. Researchers say the drug proba...be useful for treating other types of cancer. Dr. ...Bethesda, Maryland, and colleagues tested the drug...
...ox, a highly contagious virus that kills at least ...survive, was eradicated from the globe more than t...variola virus, which causes the disease, and store..., and Moscow, Russia. A smallpox attack is just on...
Other Medicine News:
(Date:9/6/2008)...monstrate Safety and Efficacy of First-in-Class Ne...he Treatment of Acute Migraine, LONDON, Sept. 6 /...nnovative biotechnology company focusing on therap...d Phase II results of its lead compound COL-144,in...ated that COL-144 was,safe and effective in reliev...
(Date:9/5/2008)... Va., Sept. 5 /- CEL-SCI Co...esented new rheumatoid arthritis data,at the Marcu... The data,presented by Dr. Daniel Zimmerman, Seni... of CEL-SCI, indicate that CEL-SCI,s rheumatoid,ar...ermanent tissue damage,caused by rheumatoid arthri...
(Date:9/4/2008)...NE, Australia, Sept. 4 /- Cytopia Lim...ing enrolment for its Phase Ib/II,study of CYT997,...r agent,in patients with an aggressive form of br..., The GBM clinical trial is the first Phase II ef...ations for the company and the second in its,suite...
(Date:9/4/2008)...a Published in ,The Lancet, and Presented at ESC C...esults from a new international,study, the GISSI H...ose of,omega-3 acid ethyl esters reduced all cause...lar reasons in patients with chronic heart,failure...ne version of ,The,Lancet, and were presented at t...
Breaking Medicine Technology:Phase II Results of COL-144 Presented at European Headache and Migraine Trust International Congress 2008 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 2Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 3Data Suggest CEL-SCI's CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis 4Cytopia Commences Second Phase II Study in Brain Cancer 2Cytopia Commences Second Phase II Study in Brain Cancer 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 2New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 3New Data Shows Prescription Omega-3 Acid Ethyl Esters Reduced the Incidence of Death in Heart Failure Patients 4Low Back Disorders Chapter Released 9839 1Low Back Disorders Chapter Released 9839 2Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday February 06 2008 9837 1Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday February 06 2008 9837 2Abortion Opponents in 59 Cities Prepare Focused 40 Day Campaign to Counter Impact of Roe v Wade 9835 1Abortion Opponents in 59 Cities Prepare Focused 40 Day Campaign to Counter Impact of Roe v Wade 9835 2Fertility Experts 3A Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 9833 1Fertility Experts 3A Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 9833 2Fertility Experts 3A Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 9833 3
...26, 2007 - Study results show,that elevated lipopr...diovascular-specific inflammatory enzyme associate...ck and stroke, is,especially predictive of heart d...e--a serious medical condition that affects nearly...sented yesterday,at the American College of Cardio...
...Problem of Antibiotic Resistance,Published in Natu...ch 26, 2007 /PRNewswire/ --,Inimex Pharmaceuticals...e system trigger to cure infections without causin...shed in the April 2007,issue of Nature Biotechnolo...ex and its,co-founders Dr. Bob Hancock and Dr. Bre...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Inimex Product Candidate is First Immune Defense Regulator to Cure,Infections Without Causing Harmful Inflammation 2
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use.
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
...d for stone manipulation and removal in the urinar... to retain its shape following extreme torsion. Th...ture by allowing the basket to open at the base of...ign reduces the likelihood of mucosal damage and p...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r
Medicine Products: